Biodesix Inc (BDSX) stock
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$8.40−0.48 (-5.41%)
Close on Nov 18, 2026Market cap $88.63MP/E –Yield –
Biodesix price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Biodesix's price to book ratio was 11.7× on Nov 11, 2026, against 5.5× a year earlier. Over the last 4 years it ranged from 3.7× to 479.9×, with a median of 136.1×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 11.7× | −81.5 |
| 2025 | Jul 31, 2025 | 93.1× | −66.7 |
| 2024 | Dec 31, 2024 | 159.8× | −248.1 |
| 2023 | Jul 31, 2023 | 407.9× | +302.6 |
| 2022 | Oct 31, 2022 | 105.3× | −73.0 |
| 2021 | Dec 31, 2021 | 178.3× | – |
See a number that looks wrong?